Cara Therapeutics, Inc. (LON:0HTC)

Cara Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 21, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	18	32	479	481	552	568
Market Cap Growth	-83.07%	-93.36%	-0.40%	-12.92%	-2.74%	41.12%
Enterprise Value	20	-28	332	341	459	383
Last Close Price	4.02	6.83	107.64	111.93	210.42	216.91
PE Ratio	-	-	-	-	89.65	-
PS Ratio	1.94	1.93	13.78	28.28	5.58	37.82
PB Ratio	23.89	0.71	3.63	2.86	3.03	4.03
P/TBV Ratio	23.89	0.71	3.63	2.86	3.03	4.03
EV/Sales Ratio	2.84	-	9.55	20.05	4.64	25.52
EV/EBITDA Ratio	-	-	-	-	111.96	-
EV/EBIT Ratio	-	-	-	-	116.31	-
Debt / Equity Ratio	62.23	0.76	0.01	0.02	0.02	0.02
Debt / EBITDA Ratio	-	-	-	-	0.79	-
Asset Turnover	0.10	0.14	0.20	0.09	0.54	0.09
Inventory Turnover	57.11	43.64	39.46	-	-	-
Quick Ratio	4.32	4.09	6.39	9.55	9.90	3.66
Current Ratio	4.77	4.54	7.20	9.84	10.55	3.86
Return on Equity (ROE)	-221.25%	-109.80%	-44.25%	-37.12%	3.86%	-66.41%
Return on Assets (ROA)	-61.79%	-49.30%	-25.49%	-21.49%	1.34%	-32.94%
Return on Capital (ROIC)	-74.81%	-58.20%	-27.92%	-22.94%	1.51%	-43.00%
Return on Capital Employed (ROCE)	-	-	-	-	2.13%	-
Earnings Yield	-396.57%	-292.78%	-14.81%	-13.58%	1.12%	-14.15%
FCF Yield	-321.08%	-233.34%	-13.65%	-9.23%	-0.77%	-14.53%
Buyback Yield / Dilution	-1.28%	-0.92%	-5.79%	-5.85%	-12.29%	-18.88%
Total Shareholder Return	-1.28%	-0.92%	-5.79%	-5.85%	-12.29%	-18.88%

Source: S&P Capital IQ. Standard template. Financial Sources.